Search research articles
Contact Us
Filters
Showing results (1-10 of 157) with videos related to
Page
of 16
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 1, 2025
The role of CMV-specific cellular immunity in transplant recipients with letermovir prophylaxis: to be determined
Yoichiro Natori, Martina Sester
Expert Review of Molecular Diagnostics
|
April 4, 2012
Screening for latent infection with Mycobacterium tuberculosis: a plea for targeted testing in low endemic regions
Delia Goletti, Martina Sester
Current Infectious Disease Reports
|
September 14, 2012
Tuberculosis in transplantation: diagnosis, prevention, and treatment
Sarah Kirsch, Martina Sester
The Lancet. Infectious Diseases
|
April 15, 2023
A novel Rift Valley fever vaccine
Saskia Bronder, Martina Sester
The Lancet. Infectious Diseases
|
July 28, 2024
A promising boost for the Rift Valley fever vaccine pipeline
Saskia Bronder, Martina Sester
Case Reports in Transplantation
|
February 18, 2016
Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient
Heinrike Wilkens, Martina Sester
Methods in Molecular Biology (Clifton, N.J.)
|
September 3, 2013
Detection of antigen-specific T cells based on intracellular cytokine staining using flow-cytometry
Tina Schmidt, Martina Sester
European Journal of Immunology
|
October 31, 2012
TB or not TB: the role of immunodiagnosis
Christoph Lange, Martina Sester
Thorax
|
December 19, 2015
What defines latent infection with Mycobacterium tuberculosis in patients with autoimmune diseases?
Martina Sester, Beate Kampmann
Lancet (London, England)
|
January 25, 2022
Boosting immunity after CoronaVac
Martina Sester, Sören L Becker
Page
of 16
Search research articles
Search
Showing results (1-10 of 157) with videos related to
Sort By:
Page
of 16
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 1, 2025
The role of CMV-specific cellular immunity in transplant recipients with letermovir prophylaxis: to be determined
Yoichiro Natori, Martina Sester
Expert Review of Molecular Diagnostics
|
April 4, 2012
Screening for latent infection with Mycobacterium tuberculosis: a plea for targeted testing in low endemic regions
Delia Goletti, Martina Sester
Current Infectious Disease Reports
|
September 14, 2012
Tuberculosis in transplantation: diagnosis, prevention, and treatment
Sarah Kirsch, Martina Sester
The Lancet. Infectious Diseases
|
April 15, 2023
A novel Rift Valley fever vaccine
Saskia Bronder, Martina Sester
The Lancet. Infectious Diseases
|
July 28, 2024
A promising boost for the Rift Valley fever vaccine pipeline
Saskia Bronder, Martina Sester
Case Reports in Transplantation
|
February 18, 2016
Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient
Heinrike Wilkens, Martina Sester
Methods in Molecular Biology (Clifton, N.J.)
|
September 3, 2013
Detection of antigen-specific T cells based on intracellular cytokine staining using flow-cytometry
Tina Schmidt, Martina Sester
European Journal of Immunology
|
October 31, 2012
TB or not TB: the role of immunodiagnosis
Christoph Lange, Martina Sester
Thorax
|
December 19, 2015
What defines latent infection with Mycobacterium tuberculosis in patients with autoimmune diseases?
Martina Sester, Beate Kampmann
Lancet (London, England)
|
January 25, 2022
Boosting immunity after CoronaVac
Martina Sester, Sören L Becker
Page
of 16